The Role of Bacteriophages in the Gut Microbiota: Implications for Human Health
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(10), P. 2416 - 2416
Published: Oct. 3, 2023
Bacteriophages
(phages)
are
nano-sized
viruses
characterized
by
their
inherent
ability
to
live
off
bacteria.
They
utilize
diverse
mechanisms
absorb
and
gain
entry
into
the
bacterial
cell
wall
via
release
of
viral
genetic
material,
which
uses
replication
host
bacteria
produce
daughter
progeny
virions
that
attack
surrounding
cells.
possess
specific
characteristics,
including
specificity
for
particular
or
closely
related
species.
have
many
applications,
as
potential
alternatives
antibiotics
against
multi-resistant
pathogens
control
agents
in
bacteria-contaminated
environments.
ubiquitously
abundant
nature
biota,
gut.
Gut
microbiota
describes
community
interactions
microorganisms
within
intestine.
As
with
bacteria,
parasitic
bacteriophages
constantly
interact
cells
gut
system
obvious
implications
human
health.
However,
it
is
imperative
understand
these
they
open
up
possible
applicable
techniques
gut-implicated
diseases.
Thus,
this
review
aims
explore
communities
current
impacts
on
Language: Английский
Bacteriophages in nature: recent advances in research tools and diverse environmental and biotechnological applications
Monish Bisen,
No information about this author
Kusum Kharga,
No information about this author
Sakshi Mehta
No information about this author
et al.
Environmental Science and Pollution Research,
Journal Year:
2024,
Volume and Issue:
31(15), P. 22199 - 22242
Published: Feb. 27, 2024
Language: Английский
An Overview of Food-Borne Pathogenic Microbes: Classification, Mode of Actions, and Recent Advances in Strategies for Management of Food-Borne Pathogens
Advances in Science, Technology & Innovation/Advances in science, technology & innovation,
Journal Year:
2024,
Volume and Issue:
unknown, P. 307 - 318
Published: Jan. 1, 2024
Language: Английский
Characterization of GQA as a novel β-lactamase inhibitor of CTX-M-15 and KPC-2 enzymes
Microbial Cell Factories,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Aug. 8, 2024
β-lactam
resistance
is
a
significant
global
public
health
issue.
Outbreaks
of
bacteria
resistant
to
extended-spectrum
β-lactams
and
carbapenems
are
serious
concerns
that
not
only
complicate
medical
care
but
also
impact
patient
outcomes.
The
primary
objective
this
work
was
express
purify
two
soluble
recombinant
representative
serine
β‑lactamases
using
Escherichia
coli
strain
as
an
expression
host
pET101/D
cloning
vector.
Furthermore,
second
evaluate
the
potential,
innovative,
safe
use
galloylquinic
acid
(GQA)
from
Copaifera
lucens
potential
β-lactamase
inhibitor.
In
present
study,
blaCTX-M-15
blaKPC-2
represented
genes
encoding
for
β-lactamases
were
cloned
parent
isolates
E.
K.
pneumoniae,
respectively,
well
purification
performed.
Moreover,
susceptibility
results
demonstrated
cells
became
all
test
(MICs;
64–128
µg/mL)
cephalosporins
128–512
µg/mL).
MICs
tested
antibiotics
determined
in
combination
with
4
µg/mL
GQA,
clavulanic
acid,
or
tazobactam
against
strains
expressing
CTX-M-15
KPC-2-β-lactamases.
Interestingly,
GQA
resulted
important
reduction
MIC
values
by
64–512-fold
susceptible
range
comparable
other
reference
inhibitors.
Additionally,
half-maximal
inhibitory
concentration
nitrocefin
substrate.
Data
showed
agent
similar
efficient
inhibitors
enzymes,
recording
smaller
IC50
(CTX-M-15;
17.51
tazobactam,
28.16
however,
KPC-2;
20.91
24.76
GQA)
compared
acid.
Our
introduces
novel
non-β-lactam
inhibitor,
which
interacts
crucial
residues
involved
recognition
hydrolysis
non-covalent
interactions,
complementing
enzyme's
active
site.
markedly
enhanced
potency
carbapenemase
β-lactamase-producing
strains,
reducing
range.
activity
makes
it
promising
lead
molecule
development
more
potent
Language: Английский
Effect of Escherichia coli on the photocatalytic behavior of TiO2 nanoparticles for H2 evolution from water
Hui Liu,
No information about this author
Jiwei Zhang,
No information about this author
Yu-jie Luo
No information about this author
et al.
International Journal of Hydrogen Energy,
Journal Year:
2024,
Volume and Issue:
79, P. 1 - 9
Published: July 4, 2024
Language: Английский
Isolation and Characterization of Novel Escherichia coli O157:H7 Phage SPEC13 as a Therapeutic Agent for E. coli Infections In Vitro and In Vivo
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(9), P. 2036 - 2036
Published: Sept. 6, 2024
O157:H7
is
a
recognized
food-borne
pathogen
causing
severe
food
poisoning
at
low
doses.
Bacteriophages
(phages)
are
FDA-approved
for
use
in
and
suggested
as
natural
preservatives
against
specific
pathogens.
A
novel
phage
must
be
identified
studied
to
develop
new
preservative
or
antimicrobial
agent
Language: Английский